title: NIDDM is associated with loss of pancreatic beta-cell L-type Ca2+ channel activity.
abstract: Development of non-insulin-dependent diabetes mellitus (NIDDM) is associated with defects in glucose-stimulated insulin secretion. We have investigated Zucker diabetic fatty rats (ZDF), an animal model of NIDDM, and found that, compared with control islets, the expression of mRNA encoding C- and D-isoforms of alpha 1-subunits of beta-cell L-type voltage-dependent Ca2+ channels (VDCC) was significantly reduced in islets isolated from ZDF rats. This correlated with a substantial reduction of L-type Ca2+ currents (ICa) in ZDF beta-cells. Intracellular Ca2+ concentration responses in ZDF islets after glucose, KCI, or BAY K 8644 stimulation were markedly attenuated, whereas responses evoked by carbachol were unimpaired, consistent with a specific decrease in ICa in the diabetic islets. This reduction was accompanied by loss of pulsatile insulin secretion from ZDF islets treated with oscillatory increases of external glucose concentration. Our findings suggest that the attenuation of ICa in diabetic islets may contribute to the abnormal glucose-dependent insulin secretory responses associated with NIDDM and indicate that this defect is caused by decreased expression of genes encoding beta-cell VDCC alpha 1-subunits.
authors.affiliation: Department of Medicine, University of Chicago, Illinois 60637; USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Roe
authors.forename: J F
authors.initials: JF
authors.lastname: Worley
authors.forename: Y
authors.initials: Y
authors.lastname: Tokuyama
authors.forename: L H
authors.initials: LH
authors.lastname: Philipson
authors.forename: J
authors.initials: J
authors.lastname: Sturis
authors.forename: J
authors.initials: J
authors.lastname: Tang
authors.forename: I D
authors.initials: ID
authors.lastname: Dukes
authors.forename: G I
authors.initials: GI
authors.lastname: Bell
authors.forename: K S
authors.initials: KS
authors.lastname: Polonsky
mesh_terms: D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000235:genetics / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000503:physiopathology; D004594:Electrophysiology; D015870:Gene Expression; D005947:Glucose / Q000494:pharmacology; D007425:Intracellular Membranes / Q000378:metabolism; D007515:Islets of Langerhans / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D009994:Osmolar Concentration; D018408:Patch-Clamp Techniques; D011189:Potassium Chloride / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011924:Rats, Zucker
chemical_list: D015220:Calcium Channels; D012333:RNA, Messenger; D011189:Potassium Chloride; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D005947:Glucose; D002118:Calcium